株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医療市場調査レビュー:2019年

2019 Healthcare Research Review

発行 BCC Research 商品コード 227024
出版日 ページ情報 英文 645 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.90円で換算しております。
Back to Top
医療市場調査レビュー:2019年 2019 Healthcare Research Review
出版日: 2019年11月20日 ページ情報: 英文 645 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

当レポートでは、BCC Researchが2019年に出版した医療機器、サービス関連のレポートから特定の調査カテゴリーのレポートを選定し、各種技術の現状と開発動向、関連法規制およびその他の市場影響因子の分析、今後の市場の展望などを抜粋し、まとめています。

第1章 序論

第2章 ポイントオブケア (POC) 診断:技術と世界市場

  • イントロダクション
  • サマリー・ハイライト
  • 主な調査結果
  • 市場セグメント
  • 一般的に実施されているPOC検査
  • Multiplex POCT (POCT)
  • 米国におけるCLIAの重要性
  • 国際市場の規模
  • 世界市場における収益
  • 世界市場における製造業者のプレゼンス
  • 血液化学・電解質検査
  • 血液化学のパラメーター
  • 血液ガス分析に対するCLIAの品質管理要件
  • 心臓マーカー検査
  • コレステロール検査
  • 薬物・アルコール乱用検査
  • グルコース検査
  • 感染症検査
  • 妊娠・受胎能検査
  • 血液・止血検査
  • 腫瘍マーカー検査
  • 尿化学検査
  • その他のPOC検査

第3章 低侵襲医療機器の世界市場

  • イントロダクション
  • サマリー・ハイライト
  • 市場分析:技術タイプ別
  • 詳細な市場分析
  • 装置/機器タイプ別市場
  • 産業構造
  • 競合および市場シェア
  • 低侵襲外科装置/器具の展望
  • 低侵襲外科装置/機器の長期的展望

第4章 組織工学および再生医療:各種技術と世界市場

  • イントロダクション
  • サマリー・ハイライト
  • 市場概要
  • 組織工学産業の進歩と将来性
  • 組織再生のためのナノテクノロジー
  • 遺伝子治療:将来の組織工学
  • 幹細胞技術
  • 市場分析・予測:セグメント別
  • 治療製品
  • 市場分析・予測:材料別
  • 合成材料
  • 生物由来材料
  • 市場分析・予測:用途別
  • 心臓血管疾患
  • 皮膚科
  • 筋骨格系
  • 整形外科
  • 骨修復・置換
  • 軟骨・結合組織損傷
  • 市場分析・予測:地域・主要国別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第5章 降圧剤の世界市場

  • イントロダクション
  • サマリーとハイライト
  • 技術・市場背景
  • 高血圧
  • 降圧剤
  • 抵抗性高血圧
  • 市場分析:薬剤クラス別
  • 世界の降圧剤市場
  • アンジオテンシン変換酵素 (ACE) 阻害薬
  • アンジオテンシンII受容体拮抗薬 (ARB)
  • ベータブロッカー
  • カルシウム拮抗剤
  • 利尿薬
  • 複合薬
  • その他
  • 世界の降圧剤市場:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第6章 放射線療法・放射性医薬品・核医学の世界市場

  • イントロダクション
  • エグゼクティブサマリー
  • 市場概要
  • 放射線治療
  • 市場の潜在性
  • 規制の展望
  • 投資分析
  • 市場シェア分析
  • 市場の分類:概要
  • 地域概要
  • 市場分析・予測:タイプ別
  • 放射線療法
  • 放射性医薬品
  • 市場分析・予測:製造法別
  • 粒子加速器 (サイクロトロン)
  • 原子炉
  • ラジオアイソトープジェネレーター
  • 市場分析・予測:技術別
  • 外照射:技術別
  • 内照射:技術別
  • 全身照射:技術別
  • 市場分析・予測:用途別
  • 外照射療法
  • 内照射療法
  • 全身照射療法
  • 市場分析・予測:地域・主要国別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域
  • 産業構造
  • 原材料の調達
  • 製造/開発プロセス
  • 流通業者
  • エンドユーザー
  • 新たな開発・現況
  • 現在の市場シナリオ

第7章 慢性腎疾患 (CKD) :世界市場・技術

  • イントロダクション
  • サマリー
  • 主な調査結果
  • 市場概要
  • 市場セグメント分析
  • 市場分析:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第8章 病院用備品の世界市場

  • イントロダクション
  • サマリー
  • 市場定義
  • 市場内訳:製品タイプ別
  • 使い捨て病院用備品
  • 手術室用機器
  • シリンジ・針
  • 移動補助・運搬装置
  • 殺菌・消毒装置
  • 患者検査装置
  • その他の病院用備品
  • 市場内訳:エンドユーザー別
  • 市場規模・予測
  • 市場内訳:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他

第9章 血液スクリーニングとタイピング:世界市場

  • イントロダクション
  • サマリー
  • 主な調査結果
  • 市場の定義
  • 市場セグメント分析
  • 核酸増幅技術
  • 免疫血液学技術
  • 微生物学技術
  • ニッチ技術
  • エンドユーザー別
  • 血液タイプ別
  • 地域別分類
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他
  • 市場シェア分析
図表

List of Tables

  • Table 1: Selected CLIA-Waived POC Tests
  • Table 2: Global Market Shares of xPOCT, by Segment, 2018
  • Table 3: Global Market for POC Testing, by Test Type, Through 2023
  • Table 4: North American Market for POC Testing, by Test Type, Through 2023
  • Table 5: European Market for POC Testing, by Test Type, Through 2023
  • Table 6: Asia-Pacific Market for POC Testing, by Test Type, Through 2023
  • Table 7: LAAM Market for POC Testing, by Test Type, Through 2023
  • Table 8: Global Market Share for POC Testing, by Major Participant, 2018
  • Table 9: Global Market Shares of xPOCT vs. Single Analyte for Blood Gas/Electrolyte Testing, 2018
  • Table 10: Global Market Shares of xPOCT vs. Single Analyte Cardiac Marker Testing, 2018
  • Table 11: Global Market Shares of xPOCT vs. Single Analyte Cholesterol Testing, 2018
  • Table 12: Global Market Shares of xPOCT vs. Single Analyte Drug Testing, 2018
  • Table 13: Global Market Shares of xPOCT vs. Single Analyte Glucose Testing, 2018
  • Table 14: Global Market Shares of Infectious Disease POC Tests, by Type, 2018
  • Table 15: Global Market Shares of xPOCT vs. Single Analyte Infectious Disease Testing, 2018
  • Table 16: Global Market Shares of Pregnancy vs. Fertility POC Tests, by Type, 2018
  • Table 17: Global Market Shares of xPOCT vs. Single Analyte Pregnancy/Fertility Testing, 2018
  • Table 18: Global Market Shares of xPOCT vs. Single Analyte Hematology Testing, 2018
  • Table 19: Global Market Shares of xPOCT vs. Single Analyte Tumor Marker Testing, 2018
  • Table 20: Global Market Shares of xPOCT vs. Single Analyte Testing for Urinalysis, 2018
  • Table 21: Global Market Shares of xPOCT vs. Single Analyte Testing for Other Tests, 2018
  • Table 22: Global Market for MIS Devices and Equipment Sales, Through 2024
  • Table 23: Global Market for MIS Devices and Equipment Sales, by Country/Region, Through 2024
  • Table 24: U.S. Market for MIS Devices and Equipment Sales, by Application, Through 2024
  • Table 25: U.S. Market for MIS Devices and Equipment Sales, by Equipment Type, Through 2024
  • Table 26: U.S. Market for MIS Devices and Equipment Sales, by End-User, Through 2024
  • Table 27: Projected Number of Persons 18 Years and Older in the U.S., Through 2024
  • Table 28: Projected Trends in Minimally Invasive Gastrointestinal Procedures, Through 2024
  • Table 29: Projected U.S. Demand for MIS Devices and Equipment Used in Gastrointestinal Surgery, Through 2024
  • Table 30: Projected Number of U.S. Women Aged Between 40 to 64 Years, Through 2024
  • Table 31: Projected Trends in Minimally Invasive Gynecological Procedures, Through 2024
  • Table 32: Projected U.S. Demand for MIS Devices and Equipment Used in Gynecological Surgery, Through 2024
  • Table 33: Number of New Cases of Selected Cancers, Through 2019
  • Table 34: Trends in Number of U.S. Women Aged over 45 Years, Through 2024
  • Table 35: Trends in Number of U.S. Boys Aged under Five Years, Through 2024
  • Table 36: Projected Trends in Minimally Invasive Urological Procedures, Through 2024
  • Table 37: Projected U.S. Demand for MIS Devices and Equipment Used in Urological Surgery, Through 2024
  • Table 38: Number of U.S. Cosmetic Surgery Procedures, Through 2018
  • Table 39: Projected Trends in Minimally Invasive Cosmetic Surgical Procedures, Through 2024
  • Table 40: Projected U.S. Demand for MIS Devices and Equipment Used in Cosmetic Surgery, Through 2024
  • Table 41: Trends in U.S. Lung Cancer Disease, Through 2019
  • Table 42: Projected Trends in Minimally Invasive Thoracic Procedures, Through 2024
  • Table 43: Projected U.S. Demand for MIS Devices and Equipment Used in Thoracic Surgery, Through 2024
  • Table 44: Projected U.S. Demand for MIS Devices and Equipment Used in Cardiac Surgery, Through 2024
  • Table 45: Projected U.S. Demand for MIS Devices and Equipment Used in Vascular Surgery, Through 2024
  • Table 46: Projected Trends in Minimally Invasive Orthopedic Procedures, Through 2024
  • Table 47: Projected U.S. Demand for MIS Devices and Equipment Used in Orthopedic Surgery, Through 2024
  • Table 48: Projected U.S. Market for MIS Device and Equipment Sales, by Application, Through 2024
  • Table 49: U.S. Medical and Surgical Equipment Manufacturers, by Employment Size and Sales Category, 2012
  • Table 50: Trends in Age Composition of the World's Population, Through 2025
  • Table 51: Projected Trends in Per-Capita Real Gross Domestic Product (GDP) Growth, by Region, 2018-2021
  • Table 52: Global Market for Tissue Engineering and Regeneration, by Region, Through 2023
  • Table 53: U.S. and European Differences in Regulatory Approval
  • Table 54: Global Market for Tissue Engineering and Regeneration, by Segment, Through 2023
  • Table 55: Global Market for Tissue Engineering and Regeneration, by Therapeutic Product, Through 2023
  • Table 56: Autologous vs. Allogenic Cells: Manufacturing Process
  • Table 57: Global Market for Cell Therapy, by Region, Through 2023
  • Table 58: Stem Cells, Advantages and Clinical Trials on Cardiovascular Disease Treatments
  • Table 59: Types of Urinary Bladder Scaffolds Proposed, 2011-2017
  • Table 60: Investments in Cell Culture Technology, 2017-2018
  • Table 61: Projects and Their Assessment Stages, 2017
  • Table 62: FDA New Molecular Entity Approval Attributes, 2017 and 2018
  • Table 63: Global Market for Tissue-Engineering, by Region, Through 2023
  • Table 64: Global Market for Gene Therapy, by Region, Through 2023
  • Table 65: Global Market for Tissue Engineering and Regeneration, by Therapeutic Material, Through 2023
  • Table 66: Global Market for Synthetic Materials, by Type, Through 2023
  • Table 67: Global Market for Synthetic Materials, by Region, Through 2023
  • Table 68: Biodegradable Polymer Classification
  • Table 69: Global Market for Biodegradable Synthetic Polymers, by Region, Through 2023
  • Table 70: Commercial Polymeric Scaffold Products
  • Table 71: Global Market for Scaffolds, by Region, Through 2023
  • Table 72: Tissue Engineered Vascular Graft Utilized in Human Studies, 2011-2017
  • Table 73: Global Market for Artificial Vascular Grafts, by Region, Through 2023
  • Table 74: Global Market for Hydrogel Technology, by Region, Through 2023
  • Table 75: Global Market for Biologically Derived Materials, by Type, Through 2023
  • Table 76: Global Market for Biologically Derived Materials, by Region, Through 2023
  • Table 77: Global Market for Biologically Derived Collagen, by Region, Through 2023
  • Table 78: Commercially Available Xenogeneic Acellular Graft
  • Table 79: Global Market for Biologically Derived Xenogenic Tissue, by Region, Through 2023
  • Table 80: Global Market for Genetically Engineered Materials, by Type, Through 2023
  • Table 81: Global Market for Genetically Engineered Materials, by Region, Through 2023
  • Table 82: Global Market for Deoxyribonucleic Acid Transfection Vectors, by Region, Through 2023
  • Table 83: Global Market for Genetically Manipulated Cells, by Region, Through 2023
  • Table 84: Global Market for 3D Polymer Technology, by Region, Through 2023
  • Table 85: List of Polymer Scaffolds Fabricated for Tissue Engineering Utilizing 3D Printing
  • Table 86: Global Market for Transgenics in Tissue Engineering, by Region, Through 2023
  • Table 87: Global Market for Fibroblasts, by Region, Through 2023
  • Table 88: Commercially Available Fibroblast Based Skin Substitute
  • Table 89: Global Market for Neural Stem Cells, by Region, Through 2023
  • Table 90: Global Market for Gene-Activated Matrix, by Region, Through 2023
  • Table 91: List of Biologics Approved, 2017
  • Table 92: Global Market for Small Molecules and Biologics, by Region, Through 2023
  • Table 93: Global Market for Tissue Engineering and Regeneration, by Application, Through 2023
  • Table 94: Global Market for Tissue-Engineering and Regeneration in Cardiovascular Applications, by Region, Through 2023
  • Table 95: Cell Therapies by Different Companies to Treat Cardiovascular Diseases
  • Table 96: Global Market for Tissue-Engineering and Regeneration in Oncology, by Region, Through 2023
  • Table 97: Global and U.S. Statistics for Skin Damage Medical Conditions, 2018
  • Table 98: Acellular Skin Tissue-Engineered Products in the Market
  • Table 99: Cellular Skin Tissue-Engineered Products in the Market
  • Table 100: Global Market for Tissue-Engineering and Regeneration in Dermatology Applications, by Region, Through 2023
  • Table 101: Global Market for Tissue-Engineering and Regeneration in Musculoskeletal Applications, by Region, Through 2023
  • Table 102: Orthopedic Diseases, by Region: Key Facts
  • Table 103: Regenerative Medicine Companies, by Size and Region, 2011
  • Table 104: Global Market for Tissue-Engineering and Regeneration, by Region, Through 2023
  • Table 105: North American Commercialized Tissue-Engineering Products
  • Table 106: North American Market for Tissue-Engineering and Regeneration, by Segment, Through 2023
  • Table 107: Tissue Engineering Research Conducted according to Different Universities
  • Table 108: Tissue-Engineering Products Offered by Different Companies
  • Table 109: Funds Allocated for Research Activities in Budget, 2016
  • Table 110: Share of Increase of Spending on Biologics in Canada, 2011-2016
  • Table 111: Shares of Tissue-Engineering Firms in Selected European Countries, 2016
  • Table 112: European Market for Tissue-Engineering and Regeneration, by Segment, Through 2023
  • Table 113: Number of Deaths across Germany on Gender Differentiation, by Cause of Death, 2017
  • Table 114: Companies That Target Different Tissue-Engineering Areas in Germany
  • Table 115: Different Causes of Death: U.K. Statistics, 2017
  • Table 116: Companies That Target Different Tissue Engineering Areas in the U.K.
  • Table 117: Companies That Target Different Tissue Engineering Areas in France
  • Table 118: European Stem Cell Policies, by Country
  • Table 119: European Companies Developing Products in Tissue Engineering and Regeneration for Central Nervous System Disorders and Injuries
  • Table 120: Asia-Pacific Market for Tissue Engineering and Regeneration, by Segment, Through 2023
  • Table 121: Rest of the World Market for Tissue-Engineering and Regeneration, by Segment, Through 2023
  • Table 122: Global Statistics for Central Nervous System Disorders and Injuries, 2015
  • Table 123: Classification of Hypertension or Blood Pressure
  • Table 124: Global Prevalence of Hypertension with Population Aged 18 Years or Older, by Country, 2015
  • Table 125: Commonly Prescribed Antihypertensive Drugs
  • Table 126: Side Effects with Different Classes of Antihypertensive Drugs
  • Table 127: Contraindications of Major Antihypertensive Drugs
  • Table 128: Global Market for Antihypertensive Drugs, by Drug Class, Through 2023
  • Table 129: Global Market for Angiotensin-Converting Enzyme (ACE) Inhibitors, by Region, Through 2023
  • Table 130: ACE Inhibitors Drug, Branded/Generic FDA Approval
  • Table 131: Global Market for Angiotensin II Receptor Blockers (ARBs), by Region, Through 2023
  • Table 132: Global Market for Beta Blocker Drugs, by Region, Through 2023
  • Table 133: Global Market for Calcium Channel Blocker Drugs, by Region, Through 2023
  • Table 134: Global Market for Diuretics Drugs, by Region, Through 2023
  • Table 135: Global Market for Combination Drugs, by Region, Through 2023
  • Table 136: Commonly Prescribed Combinations of Antihypertensive Drugs
  • Table 137: Global Market for Other Antihypertensive Drugs, by Region, Through 2023
  • Table 138: Commonly Prescribed Types of Other Antihypertensive Drugs
  • Table 139: Global Market for Antihypertensive Drugs, by Region, Through 2023
  • Table 140: North American Market for Antihypertensive Drugs, by Drug Class, Through 2023
  • Table 141: North American Market for Antihypertensive Drugs, by Country, Through 2023
  • Table 142: Total Number of High Blood Pressure Patients in Canada, by Age Group, 2016 and 2017
  • Table 143: European Market for Antihypertensive Drugs, by Drug Class, Through 2023
  • Table 144: European Market for Antihypertensive Drugs, by Country, Through 2023
  • Table 145: Asia-Pacific Market for Antihypertensive Drugs, by Drug Class, Through 2023
  • Table 146: Asia-Pacific Market for Antihypertensive Drugs, by Country, Through 2023
  • Table 147: South American Market for Antihypertensive Drugs, by Drug Class, Through 2023
  • Table 148: Middle Eastern and African Market for Antihypertensive Drugs, by Drug Class, Through 2023
  • Table 149: Milestones in the Discovery of Radioactivity and Nuclear Medicine
  • Table 150: Prevalence of Different Cancers in Top Countries, 2016
  • Table 151: Deaths from Cancers in Top Countries, by Cancer Type, 2016
  • Table 152: Summary of Regulatory Affairs Across Countries
  • Table 153: Investments in Radiopharmaceutical and Therapeutics Market
  • Table 154: Global Radiopharmaceutical Market Share Analysis, by Company, 2017
  • Table 155: Global Therapeutics Market Share Analysis, by Company, 2017
  • Table 156: Global Radiotherapy Market, by Type, Through 2023
  • Table 157: Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
  • Table 158: Global Cancer Deaths, by Type, 2016
  • Table 159: Global External Beam Radiotherapy Market, by Type, Through 2023
  • Table 160: Global External Beam Radiotherapy Market, by Region, Through 2023
  • Table 161: Global Electron-Emitting High-Energy Linear Accelerators Market, by Region, Through 2023
  • Table 162: Global Compact Radiotherapy System Market, by Type, Through 2023
  • Table 163: Global Compact Radiotherapy System Market, by Region, Through 2023
  • Table 164: Global CyberKnife Market, by Region, Through 2023
  • Table 165: Global Prevalence of Dementia, 2015, 2030 and 2050
  • Table 166: Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
  • Table 167: Global Gamma Knife Market, by Region, Through 2023
  • Table 168: Global Proton Therapy System Market, by Type, Through 2023
  • Table 169: Global Proton Therapy System Market, by Region, Through 2023
  • Table 170: Global Cyclotron Market, by Region, Through 2023
  • Table 171: Global Synchrotron Market, by Region, Through 2023
  • Table 172: Global Internal Radiotherapy/Brachytherapy Market, by Type, Through 2023
  • Table 173: Global Internal Radiotherapy/Brachytherapy Market, by Region, Through 2023
  • Table 174: Global Brachytherapy Seed Market, by Region, Through 2023
  • Table 175: Global Applicator and Afterloader Market, by Region, Through 2023
  • Table 176: Global External Brachytherapy Market, by Region, Through 2023
  • Table 177: Global Systemic Radiotherapy Market, by Region, Through 2023
  • Table 178: Global Systemic Radiotherapy Market, by Type, Through 2023
  • Table 179: Global Radiopharmaceutical Market, by Type, Through 2023
  • Table 180: Global Deaths Caused by Chronic Diseases, by Type, 2015
  • Table 181: Pharmaceutical Spending Share, by Country, 2016 (As a Percentage of Health Spending)
  • Table 182: Global Diagnostic Radiopharmaceutical Market, by Type, Through 2023
  • Table 183: Global Diagnostic Radiopharmaceutical Market, by Region, Through 2023
  • Table 184: Global PET Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
  • Table 185: Global SPECT Radiopharmaceutical Market, by Type of Radionuclide, Through 2023
  • Table 186: Global Other Diagnostic Radiopharmaceuticals Market, by Type of Radionuclide, Through 2023
  • Table 187: Global Therapeutic Radiopharmaceutical Market, by Type of Therapeutic, Through 2023
  • Table 188: Global Therapeutic Radiopharmaceutical Market, by Region, Through 2023
  • Table 189: Global Alpha Emitter Market, by Type of Radionuclide, Through 2023
  • Table 190: Global Beta Emitters Market, by Type of Radionuclide, Through 2023
  • Table 191: Global Brachytherapy Seeds Market, by Type of Radionuclide, Through 2023
  • Table 192: Global Radiopharmaceuticals Market, by Production Method, Through 2023
  • Table 193: Comparison of External Beam Radiation Therapy (EBRT) and Brachytherapy
  • Table 194: Comparison of Technologies in Radiotherapy
  • Table 195: Global External Radiotherapy Market, by Technology, Through 2023
  • Table 196: Global Particle Therapy Market, by Region, Through 2023
  • Table 197: Global Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy Market, by Region, Through 2023
  • Table 198: Global Image-Guided Radiotherapy Market, by Region, Through 2023
  • Table 199: Global Intensity-Modulated Radiotherapy Market, by Region, Through 2023
  • Table 200: Comparison of Tomotherapy and Conventional Radiotherapy
  • Table 201: Global Tomotherapy Market, by Region, Through 2023
  • Table 202: Global Three-Dimensional Conformal Radiotherapy Market, by Region, Through 2023
  • Table 203: Global Volumetric Modulated ARC Therapy Market, by Region, Through 2023
  • Table 204: Advantages and Disadvantages of Brachytherapy
  • Table 205: Various Types of Brachytherapy Implants
  • Table 206: Brachytherapy Treatment Duration
  • Table 207: Brachytherapy Treatment Dose Rate
  • Table 208: Brachytherapy Treatment Source Loading
  • Table 209: Comparison of Low-Dose and High-Dose Radiation Therapy
  • Table 210: Benefits and Drawbacks of High-Dose-Rate (HDR) Brachytherapy
  • Table 211: Comparison of Alpha and Beta Particles
  • Table 212: Benefits and Drawbacks of Radiopharmaceuticals
  • Table 213: Mechanisms of Radiopharmaceutical Localization
  • Table 214: Global Radiotherapy Market, by Application, Through 2023
  • Table 215: Global Number of Cancer Cases, 2012 and 2030
  • Table 216: Estimates for Lung Cancer in the United States for 2018
  • Table 217: Global External Beam Radiotherapy Market, by Application, Through 2023
  • Table 218: Global Internal Beam Radiotherapy Market, by Application, Through 2023
  • Table 219: Commonly Used Radionuclides (Radiation Sources) Half-Life for Brachytherapy
  • Table 220: Global Systemic Radiotherapy Market, by Application, Through 2023
  • Table 221: Global Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
  • Table 222: North American Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
  • Table 223: New Cancer Cases and Estimated Deaths, 2016
  • Table 224: Aging U.S. Population, 2000-2050
  • Table 225: North American Radiotherapy Market, by Type, Through 2023
  • Table 226: New HIV Diagnoses in the United States, by Age Group, 2016
  • Table 227: Healthcare Expenditures, by Source, Canada, 2015 and 2040
  • Table 228: North American Radiopharmaceutical Market, by Type, Through 2023
  • Table 229: Rising Aging Population (65 Years and Older) in Canada, 1996-2016
  • Table 230: European Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
  • Table 231: European Radiotherapy Market, by Type, Through 2023
  • Table 232: Estimated Number of People Living with Cancer in U.K., by Country, 2015 and 2020
  • Table 233: European Radiopharmaceutical Market, by Type, Through 2023
  • Table 234: Health Spending and Financing, 2005-2015
  • Table 235: Rising Geriatric Population in Germany, 2000-2030
  • Table 236: Rising Number of Cancer Cases in Spain, 2012 and 2015
  • Table 237: Estimate of Elderly People with Dementia (Aged 60+) in Denmark, 2017-2040
  • Table 238: Asia-Pacific Radiopharmaceutical and Therapeutics Market, by Country, Through 2023
  • Table 239: Asia-Pacific Radiotherapy Market, by Type, Through 2023
  • Table 240: Number of People with Cancer in China, 2010-2016
  • Table 241: R&D Spending in India, by Top Pharmaceutical Companies
  • Table 242: Japanese Pharmaceutical Industry, 2010-2015
  • Table 243: Estimated Most Commonly Diagnosed Cancers, by Type, 2018
  • Table 244: Commonly Diagnosed Cancer Cases in Australia, by Gender and Cancer Type, 2017
  • Table 245: Asia-Pacific Radiopharmaceutical Market, by Type, Through 2023
  • Table 246: Rest of World Radiopharmaceutical and Therapeutics Market, by Region, Through 2023
  • Table 247: Number of Cyclotrons Operating in Brazil, 2010-2015
  • Table 248: Rest of the World Radiotherapy Market, by Type, Through 2023
  • Table 249: Leading Causes of Deaths Related to Cancer in the UAE, by Cancer Type, 2015
  • Table 250: Rest of the World Radiopharmaceutical Market, by Type, Through 2023
  • Table 251: Global Suppliers for the Radiopharmaceutical and Therapeutics Market
  • Table 252: Selected Manufacturers of Instruments in Radiopharmaceutical and Therapeutics Market
  • Table 253: Cancer Deaths in Top Countries, by Type of Cancer, 2016
  • Table 254: Global Market for Chronic Kidney Disease, by Type, Through 2023
  • Table 255: Reimbursement of Dialysis Services per Week, 2011-2013
  • Table 256: Global Market for CKD Pharmaceutical Drugs, by Type, Through 2023
  • Table 257: Global Market for CKD Stage 1-5 Drugs, by Region, Through 2023
  • Table 258: Common Drug Classes Used, by Part D-Enrolled Dialysis Patients, 2013
  • Table 259: Global Market for Dialysis Drugs, by Region, Through 2023
  • Table 260: Global Market for Post-Transplantation Drugs, by Region, Through 2023
  • Table 261: Global Market for Dialysis Devices, by Type, Through 2023
  • Table 262: Global Market for Hemodialysis, by Region, Through 2023
  • Table 263: Key Peritoneal Products and Manufacturers
  • Table 264: Global Market for Peritoneal Dialysis, by Region, Through 2023
  • Table 265: Global Market for Dialysis Devices, by Product, Through 2023
  • Table 266: Global Market for Dialysis Accessories, by Region, Through 2023
  • Table 267: Global Market for Dialysis Equipment, by Region, Through 2023
  • Table 268: Global Market for Dialysate and Other Solutions, by Region, Through 2023
  • Table 269: Global Market for Dialysis Devices, by End User, Through 2023
  • Table 270: Global Market for Medical Care Centers, by Region, Through 2023
  • Table 271: Global Market for In-Home Dialysis, by Region, Through 2023
  • Table 272: Global Market for Chronic Kidney Disease, by Region, Through 2023
  • Table 273: North American Market for Chronic Kidney Disease, by Country, Through 2023
  • Table 274: European Market for Chronic Kidney Disease, by Country, Through 2023
  • Table 275: Asia-Pacific Market for Chronic Kidney Disease, by Country, Through 2023
  • Table 276: Rest of the World Market for Chronic Kidney Disease, by Country, Through 2023
  • Table 277: Global Market for Hospital Supplies, by Product Type, Through 2023
  • Table 278: Global Hospital Supply Market, by Product Type, Through 2023
  • Table 279: Global Disposable Hospital Supply Market, by Region, Through 2023
  • Table 280: Global Operating Room Equipment Market, by Region, Through 2023
  • Table 281: Global Syringe and Needle Market, by Region, Through 2023
  • Table 282: Global Mobility and Transportation Equipment Market, by Region, Through 2023
  • Table 283: Global Sterilization and Disinfectant Equipment Market, by Region, Through 2023
  • Table 284: Global Patient Examination Device Market, by Region, Through 2023
  • Table 285: Global Other Hospital Supply Market, by Region, Through 2023
  • Table 286: Global Hospital Supply Market, by End User, Through 2023
  • Table 287: North American Hospital Supply Market, by End User, Through 2023
  • Table 288: Asia-Pacific Hospital Supply Market, by End User, Through 2023
  • Table 289: European Hospital Supply Market, by End User, Through 2023
  • Table 290: Rest of the World Hospital Supply Market, by End User, Through 2023
  • Table 291: Global Hospital Supply Market, by Region, Through 2023
  • Table 292: North American Hospital Supply Market, by Country, Through 2023
  • Table 293: North American Hospital Supply Market, by Product Type, Through 2023
  • Table 294: European Hospital Supply Market, by Country, Through 2023
  • Table 295: European Hospital Supply Market, by Product Type, Through 2023
  • Table 296: Asia-Pacific Hospital Supply Market, by Country, Through 2023
  • Table 297: Asia-Pacific Hospital Supply Market, by Product Type, Through 2023
  • Table 298: Chinese Market Statistics
  • Table 299: Japanese Market Statistics
  • Table 300: Rest of the World Hospital Supply Market, by Product Type, Through 2023
  • Table 301: Rest of the World Hospital Supply Market, by End User, Through 2023
  • Table 302: Global Market for Blood Screening and Typing, by Technology, Through 2023
  • Table 303: Global Market for Blood Screening and Typing, by Technology, Through 2023
  • Table 304: Global Market for Immunoassay Tests, by Region, Through 2023
  • Table 305: Selected PCR Screening Tests, by Type
  • Table 306: Global Market for Nucleic Acid Amplification Technology, by Region, Through 2023
  • Table 307: Global Market for Immunohematology Devices, by Region, Through 2023
  • Table 308: Global Market for Microbial Techniques, by Region, Through 2023
  • Table 309: Global Market for Niche Technologies, by Region, Through 2023
  • Table 310: Global Market for Blood Screening and Typing, by End User, Through 2023
  • Table 311: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, Through 2023
  • Table 312: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, Through 2023
  • Table 313: Global Market for Blood Screening and Typing in Hospitals, by Region, Through 2023
  • Table 314: Global Market for Blood Screening and Typing, by Type, Through 2023
  • Table 315: Global Market for Donor Blood Testing Equipment, by Region, Through 2023
  • Table 316: Global Market for Patient Blood Testing Equipment, by Region, Through 2023
  • Table 317: Global Market for Blood Screening and Typing, by Region, Through 2023
  • Table 318: North American Market for Blood Screening and Typing, by Country, Through 2023
  • Table 319: European Market for Blood Screening and Typing, by Country, Through 2023
  • Table 320: Asia-Pacific Market for Blood Screening and Typing, by Country, Through 2023
  • Table 321: Donation and Distribution (JRCS 2015)
  • Table 322: RoW Market for Blood Screening and Typing, by Country, Through 2023
  • Table 323: Leading Companies, by Technology Segment

List of Figures

  • Figure 1: Global Market for POC Testing, by Test Type, 2017-2023
  • Figure 2: Global Market Share for POC Testing, by Test Type, 2018
  • Figure 3: Global Market Shares for POC Testing, by Major Participant, 2018
  • Figure 4: Global Market Shares of xPOCT vs. Single Analyte for Blood Gas/Electrolyte Testing, 2018
  • Figure 5: Global Market Shares of xPOCT vs. Single Analyte Cardiac Marker Testing, 2018
  • Figure 6: Global Market Shares of xPOCT vs. Single Analyte Cholesterol Testing, 2018
  • Figure 7: Global Market Shares of xPOCT vs. Single Analyte Drug Testing, 2018
  • Figure 8: Global Market Shares of xPOCT vs. Single Analyte Glucose Testing, 2018
  • Figure 9: Global Market Shares of Infectious Disease POC Tests, by Type, 2018
  • Figure 10: Global Market Shares of xPOCT vs. Single Analyte Infectious Disease Testing, 2018
  • Figure 11: Global Market Shares of Pregnancy vs. Fertility POC Tests, by Type, 2018
  • Figure 12: Global Market Shares of xPOCT vs. Single Analyte Pregnancy/Fertility Testing, 2018
  • Figure 13: Global Market Shares of xPOCT vs. Single Analyte Hematology Testing, 2018
  • Figure 14: Global Market Shares of xPOCT vs. Single Analyte Tumor Marker Testing, 2018
  • Figure 15: Global Market Shares of xPOCT vs. Single Analyte Testing for Urinalysis, 2018
  • Figure 16: Global Market Shares of xPOCT vs. Single Analyte Testing for Other Tests, 2018
  • Figure 17: Global Market for MIS Devices and Equipment Sales, 2018-2024
  • Figure 18: Global Market Shares of MIS Devices and Equipment Sales, by Country/Region, 2018 vs. 2024
  • Figure 19: U.S. Market Shares of MIS Devices and Equipment Sales, by Application, 2018 vs. 2024
  • Figure 20: U.S. Market Shares of MIS Devices and Equipment Sales, by Equipment Type, 2018 vs. 2024
  • Figure 21: U.S. Market Shares of MIS Devices and Equipment Sales, by End-User, 2018 vs. 2024
  • Figure 22: U.S. Market Shares of MIS Devices and Equipment Used in Gastrointestinal Surgery, 2018
  • Figure 23: U.S. Market Shares of MIS Devices and Equipment Used in Gynecological Surgery, 2018
  • Figure 24: U.S. Market Shares of MIS Devices and Equipment Used in Urological Surgery, 2018
  • Figure 25: U.S. Market Shares of MIS Devices and Equipment Used in Cosmetic Surgery, 2018
  • Figure 26: U.S. Market Shares of MIS Devices and Equipment Used in Thoracic Surgery, 2018
  • Figure 27: U.S. Market Shares of MIS Devices and Equipment Used in Cardiac Surgery, 2018
  • Figure 28: U.S. Market Shares of MIS Devices and Equipment Used in Noncardiac Vascular Surgery, 2018
  • Figure 29: U.S. Market Shares of MIS Devices and Equipment Used in Orthopedic Surgery, 2018
  • Figure 30: Employee Numbers and Sales Distribution of U.S. Medical and Surgical Equipment Manufacturers, 2012
  • Figure 31: Percentage Distribution of Monitoring/Visualization Equipment, by Market Leader, 2018
  • Figure 32: Percentage Distribution of Robotics/Computer-Assisted Surgery, by Market Leader, 2018
  • Figure 33: Percentage Distribution of Global Electrosurgical and Auxiliary Equipment, by Market Leader, 2018
  • Figure 34: Percentage Distribution of Endosurgical Instrument, by Market Leader, 2018
  • Figure 35: Percentage Distribution of Coronary Stent, by Market Leader, 2018
  • Figure 36: Global Market for Tissue Engineering and Regeneration, by Region, 2017-2023
  • Figure 37: Tissue-Engineering Strategies
  • Figure 38: Nanotechnology and Tissue Regeneration
  • Figure 39: FDA Approvals of Biologics, 2016-2018
  • Figure 40: Shares of Global Diabetes Prevalence, by Region, 2017
  • Figure 41: T-Cell Therapy Technique
  • Figure 42: Global Number of Orthopedic Surgeries, 2012-2020
  • Figure 43: Regenerative Medicine Companies, by Size and Region, 2011
  • Figure 44: United States' NIH Stem Cell Research Spending, 2013-2018
  • Figure 45: Shares of Heart Disease Deaths in the U.S., by Disease Type, 2017
  • Figure 46: Healthcare Spending in Germany, by Source, 2015 and 2040 (est.)
  • Figure 47: Pathway for Dissemination of Regenerative Medicine
  • Figure 48: Global Market Shares for Antihypertensive Drugs, by Drug Class, 2017
  • Figure 49: Global Market Shares for Antihypertensive Drugs, by Drug Class, 2017
  • Figure 50: Global Market for Angiotensin-Converting Enzyme (ACE) Inhibitors, 2017-2023
  • Figure 51: Global Market for Angiotensin-Converting Enzyme (ACE) Inhibitors, by Region, 2017-2023
  • Figure 52: Global Market for Angiotensin II Receptor Blockers (ARBs), 2017-2023
  • Figure 53: Global Market for Angiotensin II Receptor Blockers (ARBs), by Region, 2017-2023
  • Figure 54: Leading ARBs Drug Prescriptions in the U.S., 2016
  • Figure 55: Global Market for Beta Blocker Drugs, 2017-2023
  • Figure 56: Global Market for Beta Blocker Drugs, by Region, 2017-2023
  • Figure 57: Global Market for Calcium Channel Blocker Drugs, 2017-2023
  • Figure 58: Global Market for Calcium Channel Blocker Drugs, by Region, 2017-2023
  • Figure 59: Global Market for Diuretics Drugs, 2017-2023
  • Figure 60: Global Market for Diuretics Drugs, by Region, 2017-2023
  • Figure 61: Global Market for Combination Drugs, 2017-2023
  • Figure 62: Global Market for Combination Drugs, by Region, 2017-2023
  • Figure 63: Global Market for Other Antihypertensive Drugs, 2017-2023
  • Figure 64: Global Market for Other Antihypertensive Drugs, by Region, 2017-2023
  • Figure 65: Global Market Shares for Antihypertensive Drugs, by Region, 2017
  • Figure 66: North American Market Shares for Antihypertensive Drugs, by Drug Class, 2017
  • Figure 67: North American Market Shares for Antihypertensive Drugs, by Country, 2017
  • Figure 68: U.S. Market for Antihypertensive Drugs, 2017-2023
  • Figure 69: Canadian Market for Antihypertensive Drugs, 2017-2023
  • Figure 70: Mexican Market for Antihypertensive Drugs, 2017-2023
  • Figure 71: European Market Shares for Antihypertensive Drugs, by Drug Class, 2017
  • Figure 72: European Market Shares for Antihypertensive Drugs, by Country, 2017
  • Figure 73: German Market for Antihypertensive Drugs, 2017-2023
  • Figure 74: French Market for Antihypertensive Drugs, 2017-2023
  • Figure 75: U.K. Market for Antihypertensive Drugs, 2017-2023
  • Figure 76: Italian Market for Antihypertensive Drugs, 2017-2023
  • Figure 77: Spanish Market for Antihypertensive Drugs, 2017-2023
  • Figure 78: Rest of Europe Market for Antihypertensive Drugs, 2017-2023
  • Figure 79: Asia-Pacific Market Shares for Antihypertensive Drugs, by Drug Class, 2017
  • Figure 80: Asia-Pacific Market Shares for Antihypertensive Drugs, by Country, 2017
  • Figure 81: Japanese Market for Antihypertensive Drugs, 2017-2023
  • Figure 82: Chinese Market for Antihypertensive Drugs, 2017-2023
  • Figure 83: Indian Market for Antihypertensive Drugs, 2017-2023
  • Figure 84: Rest of Asia-Pacific Market for Antihypertensive Drugs, 2017-2023
  • Figure 85: South American Market for Antihypertensive Drugs, 2017-2023
  • Figure 86: South American Market Shares for Antihypertensive Drugs, by Drug Class, 2017
  • Figure 87: Middle Eastern and African Market for Antihypertensive Drugs, 2017-2023
  • Figure 88: Middle East and African Market Shares for Antihypertensive Drugs, by Drug Class, 2017
  • Figure 89: Types of Radiation
  • Figure 90: Prevalence of Different Types of Cancers in Top Countries, 2016
  • Figure 91: Deaths from Cancers in Top Countries, by Cancer Type, 2016
  • Figure 92: Global Radiopharmaceutical Market Share Analysis, by Company, 2017
  • Figure 93: Global Therapeutics Market Share Analysis, by Company, 2017
  • Figure 94: Global Cancer Prevalence and Cancer Mortality Rate, 2018 and 2030
  • Figure 95: Global Cancer Deaths, by Type, 2016
  • Figure 96: Types of Beams Used in Radiation Therapy
  • Figure 97: Common Types of Compact Advance Radiotherapy Systems
  • Figure 98: Global Prevalence of Dementia, 2015, 2030 and 2050
  • Figure 99: Global Distribution of People Living with Dementia, by Region, 2015, 2030 and 2050
  • Figure 100: Global Deaths Caused by Chronic Diseases, by Type, 2015
  • Figure 101: Pharmaceutical Spending Share, by Country, 2016
  • Figure 102: Different Types of Diagnostic Radiopharmaceuticals
  • Figure 103: Types of Therapeutic Radiopharmaceuticals
  • Figure 104: Different Production Techniques of Radiopharmaceuticals
  • Figure 105: Block Diagram of Particle Accelerators
  • Figure 106: Block Diagram of External Radiotherapy Technologies
  • Figure 107: Block Diagram of Particle Therapy/Proton Beam Therapy
  • Figure 108: Block Diagram of Stereotactic Radiosurgery
  • Figure 109: Procedure of Image-Guided Radiotherapy (IGRT)
  • Figure 110: Block Diagram of Three-Dimensional Conformal Radiation Therapy (3D-CRT)
  • Figure 111: Procedure of LDR Prostate Brachytherapy
  • Figure 112: Types of External Radiation Therapy
  • Figure 113: Global Number of Cancer Cases, 2012 and 2030
  • Figure 114: Estimated New Cases of Leukemia, Lymphoma, and Myeloma, 2018
  • Figure 115: New HIV Diagnoses in the United States, by Age Group, 2016
  • Figure 116: Canadian Healthcare Expenditures, by Source, 2015 and 2040
  • Figure 117: Rising Aging Population (65 Years and Older) in Canada, 1996-2016
  • Figure 118: Health Spending and Financing, 2005-2015
  • Figure 119: Rising Geriatric Population in Germany, 2000-2030
  • Figure 120: Rising Number of Cancer Cases in Spain, 2012 and 2015
  • Figure 121: Number of People with Cancer in China, 2010-2016
  • Figure 122: R&D Spending in India, by Top Pharmaceutical Companies, 2017
  • Figure 123: Japanese Pharmaceutical Industry, 2010-2015
  • Figure 124: Estimated Most Commonly Diagnosed Cancers, by Type, 2018
  • Figure 125: Industry Structure of Instruments and Medicines in the Radiopharmaceutical and Therapeutics Market
  • Figure 126: Global Market Shares of Hospital Supplies, by Product Type, 2017
  • Figure 127: Global Hospital Supply Market, 2017-2023
  • Figure 128: Global Hospital Supply Market Shares, by Product Type, 2017
  • Figure 129: Global Disposable Hospital Supply Market Shares, by Region, 2017
  • Figure 130: Global Operating Room Equipment Market Shares, by Region, 2017
  • Figure 131: Global Syringe and Needle Market Shares, by Region, 2017
  • Figure 132: Global Mobility and Transportation Equipment Market Shares, by Region, 2017
  • Figure 133: Global Sterilization and Disinfectant Equipment Market Shares, by Region, 2017
  • Figure 134: Global Patient Examination Device Market Shares, by Region, 2017
  • Figure 135: Global Other Hospital Supply Market Shares, by Region, 2017
  • Figure 136: Global Hospital Supply Market Shares, by End User, 2017
  • Figure 137: North American Hospital Supply Market Shares, by End User, 2017
  • Figure 138: Asia-Pacific Hospital Supply Market Shares, by End User, 2017
  • Figure 139: European Hospital Supply Market Shares, by End User, 2017
  • Figure 140: Rest of the World Hospital Supply Market Shares, by End User, 2017
  • Figure 141: Global Hospital Supply Market Shares, by Region, 2017
  • Figure 142: Global Hospital Supply Market, by Region, 2017-2023
  • Figure 143: North American Hospital Supply Market Shares, by Product Type, 2017
  • Figure 144: European Hospital Supply Market, by Country, 2017-2023
  • Figure 145: European Hospital Supply Market, by Product Type, 2017-2023
  • Figure 146: Asia-Pacific Hospital Supply Market Shares, by Product Type, 2017
  • Figure 147: Rest of the World Hospital Supply Market Shares, by Product Type, 2017
  • Figure 148: Rest of the World Hospital Supply Market Shares, by End User, 2017
  • Figure 149: Global Market for Blood Screening and Typing, by Technology, 2017-2023
  • Figure 150: Global Market Shares for Blood Screening and Typing, by Technology, 2017
  • Figure 151: Global Market for Blood Screening and Typing, by Technology, 2017-2023
  • Figure 152: Global Market Shares for Blood Screening and Typing, by Technology, 2017
  • Figure 153: Global Market for Immunoassay Tests, by Region, 2017-2023
  • Figure 154: Global Market Shares for Immunoassay Tests, by Region, 2017
  • Figure 155: Global Market for Nucleic Acid Amplification Technology, by Region, 2017-2023
  • Figure 156: Global Market Shares for Nucleic Acid Amplification Technology, by Region, 2017
  • Figure 157: Global Market for Immunohematology Devices, by Region, 2017-2023
  • Figure 158: Global Market Shares for Immunohematology Devices, by Region, 2017
  • Figure 159: Global Market for Microbial Techniques, by Region, 2017-2023
  • Figure 160: Global Market Shares for Microbial Techniques, by Region, 2017
  • Figure 161: Global Market for Niche Technologies, by Region, 2017-2023
  • Figure 162: Global Market Shares for Niche Technologies, by Region, 2017
  • Figure 163: Global Market for Blood Screening and Typing, by End User, 2017-2023
  • Figure 164: Global Market Shares for Blood Screening and Typing, by End User, 2017
  • Figure 165: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, 2017-2023
  • Figure 166: Global Market Shares for Blood Screening and Typing in Reference Laboratories, by Region, 2017
  • Figure 167: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017-2023
  • Figure 168: Global Market Shares for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017
  • Figure 169: Global Market for Blood Screening and Typing in Hospitals, by Region, 2017-2023
  • Figure 170: Global Market Shares for Blood Screening and Typing in Hospitals, by Region, 2017
  • Figure 171: Global Market for Blood Screening and Typing, by Type, 2017-2023
  • Figure 172: Global Market Shares for Blood Screening and Typing, by Type, 2017
  • Figure 173: Global Market for Donor Blood Testing Equipment, by Region, 2017-2023
  • Figure 174: Global Market Shares for Donor Blood Testing Equipment, by Region, 2017
  • Figure 175: Global Market for Patient Blood Testing Equipment, by Region, 2017-2023
  • Figure 176: Global Market Shares for Patient Blood Testing Equipment, by Region, 2017
  • Figure 177: Global Market for Blood Screening and Typing, by Region, 2017-2023
  • Figure 178: Global Market Shares for Blood Screening and Typing, by Region, 2017
  • Figure 179: North American Market for Blood Screening and Typing, by Country, 2017-2023
  • Figure 180: North American Market Shares for Blood Screening and Typing, by Country, 2017
  • Figure 181: European Market for Blood Screening and Typing, by Country, 2017-2023
  • Figure 182: European Market Shares for Blood Screening and Typing, by Country, 2017
  • Figure 183: Asia-Pacific Market for Blood Screening and Typing, by Country, 2017-2023
  • Figure 184: Asia-Pacific Market Shares for Blood Screening and Typing, by Country, 2017
  • Figure 185: RoW Market for Blood Screening and Typing, by Country, 2017-2023
  • Figure 186: RoW Market Shares for Blood Screening and Typing, by Country, 2017
  • Figure 187: Global Market Share Analysis of Blood Screening and Typing, by Company, 2017
  • Figure 188: Nucleic Acid Test Market Share Analysis, by Company, 2017
  • Figure 189: Immunoassay Tests Market Share Analysis, by Company, 2017
  • Figure 190: Immunohematology Market Share Analysis, by Company, 2017
  • Figure 191: Microbiology Market Share Analysis, by Company, 2017
目次
Product Code: HLC068H

Report Highlights:

The global minimally invasive surgical (MIS) devices and equipment sales market should reach $29.9 billion by 2024 from $21.2 billion in 2019 at a compound annual growth rate (CAGR) of 7.1% for the forecast period 2019 to 2024.

The global tissue engineering and regeneration market should reach $109.9 billion by 2023 from $24.7 billion in 2018 at a compound annual growth rate (CAGR) of 34.8% for the forecast period 2018 to 2023.

The global chronic kidney disease market should reach $95 billion by 2023 from $79 billion in 2018 at a compound annual growth rate (CAGR) of 3.8% for the forecast period 2018 to 2023.

Report Scope:

With growing demand for better healthcare infrastructure and medical needs, the healthcare industry is expected to flourish in the future. The technological advancements and robust research and development in this space, is anticipated to boost this market in the coming years. The BCC market research reports cater to the current and future needs of the healthcare market, with insights drawn from secondary and primary research. The healthcare industry is evolving in all its sub-domains such as medical devices, diagnostics, hospital supplies, and biotechnology. This report provides insights on emerging healthcare segments such as point of care diagnostics, antihypertensives and minimally invasive surgical devices.

Although, the healthcare industry is prospering, the companies are struggling in implementing effective ways to enter the market and sustain the competition, with thorough market knowledge.

Table of Contents

Chapter 1: Foreword

  • Foreword

Chapter 2: Point-of-Care Diagnostics: Technologies and Global Markets (HLC043F)

  • Introduction
    • Study Goals and Objectives
    • Reasons for Doing the Study
    • Contribution of the Study and Intended Audience
    • Scope of Report
    • Defining POC Testing
    • Methodology
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Major Findings
  • POC Product Segments
    • Blood Chemistry and Electrolytes
    • Cardiac Marker
    • Cholesterol Testing/Monitoring
    • Drug and Alcohol Screening
    • Glucose Testing and Monitoring
    • Infectious Disease Testing
    • Pregnancy and Fertility Testing
    • Hemoglobin and Hemostasis
    • Tumor Marker
    • Urinalysis/Urine Chemistry
  • Commonly Performed POC Tests
  • Multiplex POCT (xPOCT)
  • Significance of CLIA in the United States
  • International Market Size
  • Global Market Revenues
    • North America
    • Europe
    • Asia-Pacific
    • LAAM
  • Presence of Manufacturers in the Worldwide Market
    • Competitor Market Share
  • Blood Chemistry and Electrolyte Testing
  • Blood Chemistry Parameters
    • Electrolytes
  • CLIA Quality Control Requirements for Blood Gas Analysis
  • Market Size
    • xPOCT Market Share
  • Cardiac Marker Testing
  • Market Size
    • xPOCT Market Share
  • Cholesterol Testing
  • Market Size
    • xPOCT Market Share
  • Drug and Alcohol Abuse Testing
  • Market Size
    • xPOCT Market Share
  • Glucose Testing
  • Market Size
    • xPOCT Market Share
  • Infectious Disease Testing
  • Market Size
    • xPOCT Market Share
  • Pregnancy and Fertility Testing
  • Market Size
    • xPOCT Market Share
  • Hemoglobin/Hemostasis Testing
    • Hematology and Hemostasis
  • Hemostasis (Coagulation)
  • Market Size
    • xPOCT Market Share
  • Tumor Marker Testing
  • Fecal and Gastric Occult Blood
  • Bladder Tumor Antigen Test
  • Market Size
    • xPOCT Market Share
  • Urine Chemistry Testing
  • Market Size
    • xPOCT Market Share
  • Other POC Tests
    • Vaginal pH Tests
    • Thyroid Stimulating Hormone Tests
    • Male Reproductive Tests
    • Menopause
    • Dry Eye
  • Market Size
    • xPOCT Market Share

Chapter 3: The Market for Minimally Invasive Medical Devices (HLC051H)

  • Introduction
    • Reasons for Doing This Study
    • Study Goals and Objectives
    • Scope of Report
    • Information Sources
    • Methodology
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Market Breakdown by Technology Type
    • Geographic Segments
    • Application Segments
    • Device and Equipment Segments
    • End-User Segments
  • Detailed Market Analysis
    • Minimally Invasive Gastrointestinal Surgery
    • Minimally Invasive Gynecological Surgery
    • Minimally Invasive Urological Surgery
    • Minimally Invasive Cosmetic Surgery
    • Minimally Invasive Thoracic Surgical Procedures
    • Minimally Invasive Cardiothoracic Surgery
    • Minimally Invasive Noncardiac Vascular Interventional Surgery
    • Minimally Invasive Orthopedic surgery
  • Market by Type of Device and Equipment
  • Industry Structure
  • Competition and Market Shares
    • Monitoring/Visualization Equipment
    • Robotics/Computer-Assisted Surgery
    • Electrosurgical Equipment
    • Surgical Instruments
    • Surgical Devices
  • The Outlook for Minimally Invasive Surgical Devices and Instruments
    • Technological Developments
    • Demographic and Economic Trends
    • Changing Structure of the Healthcare Industry
  • Long-Term Outlook for Minimally Invasive Surgical Devices and Equipment

Chapter 4: Tissue Engineering and Regeneration: Technologies and Global Markets (HLC101D)

  • Introduction
    • Study Goals and Objectives
    • Scope of Report
    • Intended Audience
    • Source of Information and Methodology
    • Geographic Breakdown
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Market Overview
  • Progress and Promises for Tissue-Engineering Industry
    • Body Parts That Can be Replaced by Tissue Engineering
  • Nanotechnology for Tissue Regeneration
    • Effects of Nanotechnology on Stem Cell Behavior for Tissue Regeneration
    • Nanotechnology in Tissue Regeneration Applications
  • Gene Therapies: The Future of Tissue Engineering
    • Progress
    • Prospects
  • Stem Cell Technologies Boon to Tissue Engineering
  • Market Breakdown by Segment
  • Therapeutic Products
    • Cell Therapy
    • Tissue Vascularization
    • Cell Culturing
    • Small Molecules and Biologics
    • Tissue Engineering
    • Gene Therapy
  • Market Breakdown by Material
  • Synthetic Materials
    • Biodegradable Synthetic Polymers
    • Scaffolds: Medical Poly Lactic Acid
    • Artificial Vascular Graft Materials
    • Hydrogel Technology
  • Biologically Derived Materials
    • Collagen
    • Xenogenic Tissue
    • Genetically Engineered Materials
  • Market Breakdown by Application
  • Cardiovascular Disorders
    • Peripheral Vascular Disease Applications
    • Coronary Artery Disease
  • Oncology
  • Dermatology
  • Musculoskeletal
  • Orthopedics
  • Bone Repair and Replacement
  • Cartilage and Connective Tissue Damage
  • Market Breakdown by Region
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Other European Countries
  • Asia-Pacific
    • India
    • Japan
    • China
    • Australia
    • Rest of Asia-Pacific
  • Rest of the World
    • Cartilage and Bone Tissue-Engineering Products
    • Cardiovascular Disease Products
    • Central Nervous System-Related Injuries and Diseases

Chapter 5: Antihypertensives: Global Markets to 2023 (HLC159A)

  • Introduction
    • Study Goals and Objectives
    • Reasons for Doing This Study
    • Scope of Report
    • Information Sources
    • Methodology
    • Geographic Breakdown
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Market and Technology Background
  • Hypertension
    • Pathophysiology and Pathogenesis
    • Classification
    • Prevalence of Hypertension
  • Antihypertensive Drugs
    • Commonly Prescribed Antihypertensive Drugs
    • Side Effects of Antihypertensive Drugs
    • Contraindications of Major Antihypertensive Drugs
  • Resistant Hypertension
  • Market Breakdown by Drug Class
  • Global Antihypertensive Drug Market
  • Angiotensin-Converting Enzyme (ACE) Inhibitors
    • Market Size and Forecast
    • Market Analysis
  • Angiotensin II Receptor Blockers
    • Market Size and Forecast
    • Market Analysis
  • Beta Blockers
    • Market Size and Forecast
    • Market Analysis
  • Calcium Channel Blockers
    • Market Size and Forecast
    • Market Analysis
  • Diuretics
    • Market Size and Forecast
    • Market Analysis
  • Combination Drug
    • Market Size and Forecast
    • Market Analysis
  • Others
    • Market Size and Forecast
    • Market Analysis
  • Global Market for Antihypertensives by Region
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • South America
    • Market Size and Forecast
    • Market Analysis
  • Middle East and Africa
    • Market Size and Forecast
    • Market Analysis

Chapter 6: Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176C)

  • Introduction
    • Study Goals and Objectives
    • Reasons for Doing This Study
    • Scope of Report
    • Information Sources
    • Methodology
    • Geographic Breakdown
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Market Overview
    • Radiopharmaceuticals
    • Uses of Radiopharmaceuticals
  • Evolution and Transition: Radiopharmaceuticals
  • Radiotherapy
    • Ionizing Radiation
    • Non-ionizing Radiation
  • Evolution and Transition: Radiation Therapy
    • The Discovery Period: 1890s
    • Kilovoltage Era: 1900 to 1940
    • Megavoltage Era: 1946 to 1996
    • Computer-Assisted Era: 1996 to the Present
  • Market Potential
  • Regulatory Outlook
    • United States
    • Canada
    • Australia
    • India
    • European Union
  • Investment Analysis
  • Market Share Analysis
  • Segmentation Overview
    • Segmentation by Type: Radiotherapy
    • Segmentation by Type: Radiopharmaceuticals
    • Segmentation by Production Method
    • Segmentation by Technology
    • Radiopharmaceutical and Therapeutics Market, by Application
  • Geographic Overview
    • North America
    • Europe
    • Asia-Pacific
    • RoW
  • Global Radiopharmaceutical and Therapeutics Market by Type
  • Radiotherapy
    • External Beam Radiation Therapy
    • Internal Radiation Therapy
    • Systemic Radiotherapy
  • Radiopharmaceuticals
    • Diagnostics
    • Therapeutics
  • Global Radiopharmaceutical and Therapeutics Market by Production Method
  • Particle Accelerators (Cyclotrons)
    • Working of Particle Accelerators
  • Nuclear Reactors
  • Radionuclide Generators
    • Production of Radioisotopes Through Radionuclides
  • Global Radiopharmaceutical and Therapeutics Market by Technology
  • External Radiotherapy Market by Technology
    • Particle Therapy/Proton Beam Therapy
    • Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
    • Image-Guided Radiation Therapy (IGRT)
    • Intensity-Modulated Radiation Therapy (IMRT)
    • Tomotherapy
    • Three-Dimensional Conformal Radiation Therapy (3D-CRT)
    • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiotherapy by Technology
    • Pulsed-Dose-Rate (PDR) Brachytherapy
    • Low-Dose-Rate Brachytherapy
    • High-Dose-Rate (HDR) Brachytherapy
  • Systemic Radiotherapy by Technology
    • Comparison between Alpha and Beta Emitters
  • Global Radiopharmaceutical and Therapeutics Market by Application
  • External Beam Radiation Therapy
    • Treatment Planning for External Beam Radiation
    • Dosing and Treatment with External Beam Radiation
    • Electron-Emitting High-Energy Linear Accelerators (LINACS)
  • Internal Radiation Therapy
    • Applications of Internal Beam Radiation Therapy
  • Systemic Radiation Therapy
    • Applications of Systemic Radiation Therapy
  • Geographic Analysis
  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • France
    • Germany
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Rest of the World (ROW)
    • Latin America
    • Middle East and Africa
  • Industry Structure
  • Raw Material Procurement
    • Quality
    • Terms and Conditions
    • Cost-Effective Components
  • Manufacturing/Development Process
  • Distributors
  • End Users
  • New Development and Current Situation
  • Current Market Scenario
    • Current Developments in Radiopharmaceuticals and Therapies

Chapter 7: Chronic Kidney Disease: Global Markets and Technologies Through 2023 (HLC214A)

  • Introduction
    • Study Goals and Objectives
    • Reasons for Doing This Study
    • Scope of Report
    • Methodology
    • Geographic Breakdown
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Key Findings
  • Market Overview
    • The U.S.
    • Canada
    • Japan
    • Germany
    • France
    • Italy
    • The UK
    • Brazil
    • Other Countries - China, India and Spain
  • Market Segment Analysis
    • Segment Analysis, by Treatment Intervention
    • Pharmaceutical Drugs
    • Medical Device Interventions-Dialysis
    • Analysis of Medical Device Intervention, by Product
    • Analysis of Medical Device Intervention/Dialysis Market, by End User
  • Market Breakdown by Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
  • Asia-Pacific
    • China
    • India
    • Japan
  • RoW
    • Latin America
    • Africa
    • Middle East

Chapter 8: Hospital Supplies: Global Markets to 2023 (HLC220A)

  • Introduction
    • Study Goals and Objectives
    • Scope of Report
    • Information Sources
    • Methodology
    • Geographic Breakdown
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Market Definitions
    • Hospital Supplies
    • Disposable Hospital Supplies
    • Mobility Aids and Transportation Equipment
    • Operating Room Equipment
    • Patient Examination Devices
    • Sterilization and Disinfectant Equipment
    • Syringes and Needles
  • Market Breakdown by Product Type
  • Disposable Hospital Supplies
    • Market Size and Forecast
    • Market Competition
  • Operating Room Equipment
    • Operating Room Lights
    • Operating Room Tables
    • Market Size and Forecast
    • Market Competition
  • Syringes and Needles
    • Syringe Alternatives
    • Syringe Innovations
    • Warnings Against Reusing Plastic Syringes
    • Needlestick Safety
    • Market Size and Forecast
    • Market Competition
  • Mobility Aids and Transportation Equipment
    • Market Size and Forecast
    • Market Competition
  • Sterilization and Disinfectant Equipment
    • Steam Bulk and Tabletop Sterilizers
    • Ethylene Oxide Sterilizer
    • Market Size and Forecast
    • Market Competition
  • Patient Examination Devices
    • Thermometers
    • Stethoscopes
    • Market Size and Forecast
    • Market Competition
  • Other Hospital Supplies
    • Market Size and Forecast
  • Market Breakdown by End User
  • Market Size and Forecast
  • Market Breakdown by Region
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • Russia
    • United Kingdom
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Rest of the World (ROW)

Chapter 9: Blood Screening and Typing: Global Markets (HLC224A)

  • Introduction
    • Scope of Report
    • Information Sources
    • Methodology
    • Geographic Breakdown
    • Analyst's Credentials
    • Related BCC Research Reports
  • Report Summary
  • Key Findings
  • Market Definition
    • Blood Screening
    • Blood Grouping and Typing
  • Market Segment Analysis
    • Segment Analysis, by Technology
    • Immunoassay
    • Market Size and Forecast
  • Nucleic Acid Amplification Technology
    • Polymerase Chain Reaction Amplification
    • Other Nucleic Acid Amplification Technologies
    • Market Size and Forecast
  • Immunohematology (Blood Typing) Techniques
    • Manual Typing Methods
    • Automated Blood Typing
    • Market Size and Forecast
  • Microbial Techniques
    • Blood Stream Infections
    • Blood Cell Culture and Antimicrobial Susceptibility Testing
    • BioMerieux's VITEK 2 System
    • Becton, Dickinson and Company's BD Phoenix Identification and Susceptibility Testing System
    • Market Size and Forecast
  • Niche Emerging Technologies
    • DNA Sequencing
    • Microarray
    • Market Size and Forecast
  • Segment Analysis, by End User
    • Reference Laboratories
    • Standalone Blood Banks
    • Hospitals
  • Segment Analysis, by Blood Type
    • Donor Blood
    • Patient Blood
    • Market Breakdown by Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Rest of the World (RoW)
    • South America
    • Middle East and Africa
  • Market Share Analysis
  • Market Share Analysis in the Nucleic Acid Test Segment
  • Market Share Analysis in the Immunoassay Tests Segment
  • Market Share Analysis in the Immunohematology Segment
  • Market Share Analysis in the Microbiology Segment
Back to Top